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Chapter I 
INTRODUCTION
The Shope rabbit fibroma was discovered in 1932 by 
Richard E* Shope of the Rockefeller Institute in Princeton, 
New Jersey, when he observed small fibromatous tumors 
under the skin of a wild cottontail rabbit which he shoto 
The tumor was transmissible by means of tissue filtrates 
to wild cottontail and domestic rabbits® The tissue fil­
trates given to domestic rabbits produced fibromatous 
tumors similar to those found naturally (usually on the 
feet) in wild cottontail rabbits. When transmitted by 
inoculation to either the domestic or the cottontail rabbit, 
the tumors grew initially quite rapidly but became 
stationary and regressed in about 9-12 days, leaving the 
rabbit immune to subsequent infection (Allison, 1966).
The Natural Reservoirs of Shope Rabbit Fibroma 
The natural reservoirs of Shope rabbit fibroma appear 
to be the wild cottontail rabbit. Kilham and Woke (1953) 
demonstrated that fleas and Aedes aegypti mosquitoes fed 
on fibromatous tumors on wild cottontail rabbits trans­
mitted typical fibromas, usually on the feet and legs, to 
healthy cottontail rabbits. These insects retained the 
ability to transmit the tumor for at least 2 weeks after 
feeding on a tumor. In 1955 Kilham and Dalmat found that 
three other species of mosquitoes. Anopheles quadrimaculatus.
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Culex pipens, and Aedes triseriatus, were as effective in 
transmitting the Shope rabbit fibroma virus as Aedes 
aegypti. They also found that the infected mosquitos 
carried the virus, which was localized in the head parts, 
for as long as several weeks. The Shope rabbit fibroma, 
though it can be easily transmitted by culture filtrates 
and insect bites, is not contagious.
Relationship of Fibroma and Myxoma Virus
Fibroma and myxoma viruses appear to be very closely 
related, although the diseases they produce are quite dif­
ferent. Fibroma virus, normally not fatal, produces a local, 
benign, fibromatous tumor which usually regresses in domes­
tic and cottontail rabbits, and is not transmitted by direct 
contact. Myxoma virus induces an acute, generalized disease 
transmissible by direct contact. The disease is fatal only 
for domestic rabbits, whereas cottontail rabbits develop only 
a transient localized infection evidenced by a fibromatous 
tumor at the site of inoculation. This lesion is similar 
to that induced by fibroma virus in cottontail rabbits.
The similarity in these lesions led Shope (1932) to postu­
late an immunological relationship between the two viruses.
He found that recovery from an infection with fibroma virus 
decreased susceptibility to a subsequent infection with 
myxoma virus.
After recovery from infection with fibroma virus, 
domestic rabbits inoculated with myxoma virus developed a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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local myxoma which showed little tendency to generalize. 
Most of the animals recovered, suggesting that fibroma 
infection provided some degree of protection against 
myxoma virus. Cross-immunity was very difficult to demon­
strate in the opposite direction as almost all domestic 
animals with primary myxomatosis died. The very rare rab­
bit surviving primary myxomatosis proved to be immune to 
subsequent inoculations with either myxoma or fibroma 
virus.
From these studies it is evident that animals infected 
with fibroma or myxoma virus develop cross-immunity and 
that the viruses are closely related (Shope, 1936). The 
closeness of this relationship was demonstrated in 1939 by 
Berry and Dedrick, who accomplished the transformation of 
fibroma virus into nqrxoma virus. Myxoma virus was heat- 
inactivated at either 60°C or 73^C and mixed with live 
fibroma virus. This preparation, when injected into the 
testicles of normal domestic rabbits, frequently produced 
generalized myxomatosis leading to death of the animal.
A control of heated myxoma alone did not produce disease. 
These findings were later confirmed by Hust (1937), Shope 
(1950) and Smith (1952).
Kilham (1957 and 195^) found that the fibroma—myxoma 
transformation could be accomplished in tissue culture by 
adding heat-inactivated myxoma virus (67°C for 40 minutes) 
to live fibroma virus growing in either rabbit kidney cells
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
or rabbit testis cells. The mechanisms of this 
transformation are not known, but an exchange of genetic 
information must be supposed.
Physical and Chemical Characteristics 
Myxoma and fibroma viruses have many characteristics 
in common, neither agglutinate red blood cells (Fenner, 
1953)» and both are sensitive to ethyl ether and produce 
acidophilic intracytoplasmic inclusion bodies in the epi­
thelial cells of infected skin lesions and in the ectodermal 
cells of the chorioallantoic membrane of chicken embryos.
The diameter of the virus particles is approximately 175 nm 
(Schlesinger and Andrews, 1937) by filtration and centri­
fugation techniques, while electron microscopy gives a 
diameter of about 230-2Ô0 nm. The viruses are closely 
related to vaccinia, fowlpox and ectromelia (Fenner, 1953» 
Gaylord and Melnick, 1953) except that the latter three are 
not susceptible to ethyl ether. Cross-immunization and gel 
diffusion tests indicate that rabbit fibroma virus is more 
closely related to myxoma than to squirrel fibroma virus 
(Woodroffe and Fenner, 1965)* Electron micrographs have 
shown that fibroma and myxoma viruses have typical pox 
virus morphology (Farrant and Fenner, 1958» Gaylord and 
Melnick, 1953» Morgan, , 1954; Dernhard, 1958) and
are similar in structure (Barnhard, et ^ . , 1954; Lloyd and 
Kahler, 1955» Scherrer, I960). Barnhard, et al. (1954)
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examined ultra-thin sections of fibroma lesions and found 
the virus to be an ovoid particle, approximately 230 nm in 
diameter. Outside of the infected cell the virus may have 
a brick-shaped structure (Scherre, I960). The virus 
particles are usually found in the cytoplasm of the infected 
cell, often aggregate near the cell nucleus, and are visible 
as Feulgen-positive inclusion bodies by light microscopy 
(Constantin and Febvre, 1956 and 1956).
Tissue Cultures
Faulkner and Andrews (1935) and later Kilham (1956) 
propogated fibroma virus in tissue culture of rabbit testis. 
This cultured virus was fully infective to rabbits. The 
titer of virus increased after each passage and a maximum 
titer of 10”^ was reached in about two weeks after which a 
gradual decline began concomitantly with a decrease in via­
bility of the tissue culture cells. No cell death was 
attributable to virus proliferation, Constantin and Bauer 
(1956) reported similar results.
Growth of the virus in tissue culture cells was 
accompanied by the formation of acidophilic intracytoplasmic 
inclusion bodies (Kilham, 1956; Constantin and Febvre, 1956, 
1956; Constantin, e^ al. 1956) similar to those noted by 
Shope (1932) in fibromas from wild cottontail rabbits.
The virus caused cell destruction in primary kidney 
and skin cultures from newborn rabbits (Verna and Eylar,
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1962) and in cell monolayers, produced plaques measuring 
from 1 to 2 mm in diameter within four to five days.
Immune serum accentuated the production of these plaques 
(Moore and Walker, 1962). The virus titers determined by 
the plaque technique were similar to those obtained by 
the titration in the skins of rabbits. Hinze and Walker 
(1964) successfully propagated fibroma virus, not only in 
primary kidney cell cultures, but also in serially—cultured 
rabbit kidney cells. After infection these cells lost 
contact inhibition and numerous intracytoplasmic inclusion 
bodies were observed. The transformed cells were able to 
induce formation of tumors when inoculated into the cheek 
pouch of the hamster.
Induction of Generalized Fibromatosis in Rabbits
Although fibroma virus usually produces a mild, benign 
and localized lesion in rabbits, under some circumstances 
generalized and fatal fibromatosis can be produced. Andrews 
and Ahlstrom (193^) observed that the regression of viral 
lesions normally seen was modified by an intramuscular 
injection of tar. Some of the subcutaneous tumors grew 
progressively and produced métastasés. Generalized fibro­
matosis, sometimes fatal, resulted after intravenous (i.v.) 
injection of virus into tarred animals. A single dose of 
the tar, or of benzpyrine and other carcinogens, on the 
day of virus inoculation was sufficient to produce these
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
results. A fibrosarcoma, isolated from a rabbit which had 
received 2 intramuscular injections of tar 4 months apart 
followed by an i.v. injection of fibroma virus, was trans­
planted through a series of 12 rabbit passages. The first 
of these transplanted tumors regressed, but many of the 
tumors of later passages grew progressively and some métas­
tasés occurred. Virus particles could not be isolated from 
the tumor. By giving 300-700 R of total body irradiation 24- 
hours prior to i.v. injection of fibroma virus, generalized 
fibromatosis could also be induced (Clemmesen, 1939)» 
Treating rabbits with cortisone after inoculation with 
fibroma virus also retards the regression of the tumors 
and sometimes results in generalized fibromatosis (Harel 
and Constantin, 1954; Allison and Friedman, 1966). Treat­
ment of infected animals with methotrexate retards tumor 
regression and may lead to métastasés (Allison and Friedman,
1966).
Fibromatosis in Newborn Rabbits 
Inoculation of fibroma virus into newborn rabbits 
produces either a generalized, fatal disease or a general­
ized or local nonfatal fibrosarcoma. Occasionally, a 
metastasizing sarcoma can be induced. The age of the rabbit 
and the dose of inoculum are the deciding factors for the 
type of disease produced (Duran-Reynals, 1940, 1945;
Allison, 1966).
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Immunological Aspects 
Duran-Reynals (1940, 1945) found that after injection 
of virus into adult domestic rabbits, virus was present in 
the viscera during the first 8 days of infection, but 
viremia did not develop. Immunity to reinfection was 
demonstrable 24 hours after infection and the antibody 
response was prompt and vigorous. However, following simi­
lar injections into newborn animals, virus could be detect­
ed in the blood for at least 13 days and in the viscera for 
at least 21 days. Immunity to reinfection was not well 
established 12 days after infection, the antibody response 
developed slowly, and the titers were low. When large 
amounts of virus were injected into newborn rabbits, an 
acute lethal disease with destructive, inflammatory, and 
proliferative features resulted. This disease closely 
resembled fatal myxomatosis of adult domestic rabbits. If 
small amounts of virus were injected into newborn rabbits, 
a progressively-growing tumor and métastasés resulted, 
occasionally followed by fatal generalized fibromas. In 
some cases, the tumor regressed after reaching a large size. 
These generalized lesions were similar to the generalized 
fibromas obtained in rabbits prepared by carcinogens, 
immunosuppressants, or whole body irradiation followed by 
intravenous injection of fibroma virus.
Allison (1966) and Allison and Friedman (1966), in a 
series of experiments with adult and newborn domestic
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
rabbits, concluded that recovery from initial infections and 
immunity to subsequent infections with rabbit fibroma virus 
was due to a cell-mediated immune response* Adult animals 
inoculated with Shope rabbit fibroma developed tumors which 
began to regress on about the 9th day* Delayed-type hyper­
sensitivity reactions could be demonstrated by intradermal 
injection with virus antigen on the 5th day, and circulat­
ing antibody could be demonstrated on the 7th day. Rabbits 
inoculated with virus shortly after birth developed tumors 
which grew progressively. Circulating antibody could be 
demonstrated in the newborns on the 7th or 6th day, but no 
delayed-type reaction could be elicited even by the passive 
transfer of lymph node cells into the skin of adult rabbits 
bearing fibromas *
In adult domestic rabbits treated with methotrexate, 
an inhibitor of delayed-type hypersensitivity and antibody 
formation, regression of fibroma was retarded to the extent 
that the tumors became larger than those in control rabbits. 
Secondary fibromas developed at sites distant from the orig­
inal inoculation site. Secondary injections of fibroma 
virus into rabbits infected with fibroma virus and treated 
with methotrexate on the 5th and 7th days induced fibromas 
at these sites, while untreated, infected animals were re­
sistant to reinfection. Hyperimmune antifibroma serum 
administered to the methotrexate—treated rabbits prevented 
the formation of secondary fibromas but did not produce
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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necrosis or regression of the fibromas. In animals 
treated with cortisone, delayed hypersensitivity was 
suppressed, but some antibody was formed. Regression of 
fibromas in these animals was retarded, and no secondary 
lesions developed. From these results it was postulated 
that regression of the fibromas is not due to interferon 
or any other factor inherent in the fibroma cells but to 
a cell-mediated immune response. Humoral antibody was 
thought to prevent the formation of secondary fibromas but 
not to be important in the regression of the primary tumor.
Tompkins, et aJ.. (1969) developed an in vitro measure 
of cellular immunity to the fibroma virus ; a modification 
of the macrophage inhibition test employing infected mono­
layers of PRK cells as the source of antigen. The capacity 
of these monolayers of infected cell homogenates to inhibit 
migration of peritoneal exudate cells from fibroma-infected 
rabbits paralleled the onset of a cutaneous delayed hyper­
sensitivity response and resistance to reinfection in the 
intact animal. Studies using antigens prepared at differ­
ent intervals after infection of cells with the virus 
suggested that the test is a measure of specific antigen(s) 
associated with the cell surface rather than those compon­
ents of the intact viron. Immune serum did not prevent the 
antigen from inhibiting migration of sensitized cells but 
enhanced inhibition.
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Tompkins, et (1971) characterized the surface 
antigen on cells infected by fibroma virus which developed 
a surface antigen detectable by immunofluorescence• Sera 
from rabbits with regressed fibroma—induced tumors reacted 
with the surface of viable fibroma-infected cells, but not 
with cells infected with vaccinia virus, herpesvirus. Serum 
prepared against vaccinia virus, herpesvirus SV40, and 
rabbit papilloma virus did not react with fibroma—infected 
cells. The surface antigen seems to develop late and to 
depend upon DNA synthesis. The antibody did not react with 
intact virons attached to the cell surface. The antigen 
persisted in associated with the cell membrane long after 
infectious virus had decreased to low levels. A temporal 
relationship between the surface antigen measured by the 
innumo-fluorescent technique and the antigen measured by 
the macrophage inhibition test could be demonstrated. Anti­
body reactive against the surface antigen developed in rab­
bits with growing fibromas, and the antibody titer increased 
as the tumor regressed.
Statement of Problem
Based upon previous work by Allison (1966) and Allison 
and Friedman (1966) this study was proposed to further 
elucidate the immune mechanisms involved in recovery from 
Shope rabbit fibroma. Humoral and cell-mediated aspects 
of the problem were investigated as well as specific and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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non-specific components of the immune response* Adult 
and neonatal rabbits were employed*
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Chapter II 
MATERIALS AND METHODS
Animals
Adult New Zealand rabbits of both sexes, weighing 
5-7 kg, obtained from local breeders were used throughout 
the investigation. Newborn rabbits of mixed breed from 
a breeding colony maintained by the author were also 
employed. All newborn animals were injected with virus at 
36 hours of age and weaned at 6 weeks. The adult animals 
were given food and water ^  libitun.
Virus Strain
The Patuxent strain of the Shope rabbit fibroma was 
obtained from the American Type Culture Collection (ATCC 
Lot No. 2). The strain, of an unknown passage in rabbits, 
was donated by Dr. Lawrence Kilham. The virus was propa­
gated in rabbit testes which were harvested, ground, and 
resuspended in Minimum Essential Medium (MEM), Grand Island 
Biological Supply Co., Oakland, California. The cultured 
virus was placed in 1 ml volumes in sealed ampules and 
stored at -70°C. This stock virus induced tumors when .2 
ml of a 10“^ dilution was given to rabbits. All animals 
were injected intradermally with .2 ml of a 10“’̂  dilution 
of the original virus suspension.
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BCG Strain
The Paris strain of Mycobacterium bovis, Bacille- 
Calraette-Guerin (BCG) maintained on Dubos medium, Difco, 
Detroit, Michigan, was employed for vaccination of the 
animals. A .2 ml volume of a suspension containing 2.4 
X 10^ organisms per ml, adjusted to the concentration by 
use of a Klett—Summerson Photoelectric colorimeter. New 
York, was used. The organisms were injected intravenously 
(i.v.).
Skin-Test Antigens
Two-tenths ml of PPD (NIH, Bethesda, Maryland)
containing 8 ug was used for skin tests. To test for skin
— 1 — ?sensitivity to the virus .2 ml of a 10 and 10” dilution 
of the stock virus suspension heated at 56°C for 30 minutes 
was used.
Preparation of Immune Serum, Buffy Coat, Peritoneal 
Exudate Cells (PEC) and Spleen Cells 
The flanks of rabbits were shaven and 10 intradermal 
(i.d.) injections of virus suspension were given. When 
tumor began to regress, the animals received 30 ml of 
sterile mineral oil intraperitoneally (i.p.). Seventy-two 
hours later they were bled by cardiac puncture and sacri­
ficed. Blood from half of the animals was drawn in versine- 
coated syringes (to prevent clotting) and 10 ml amounts were 
administered i.v. to experimental animals. Blood of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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remaining animals was allowed to clot, centrifuged, and 
the serum was removed. The serum was also given i.v. in 
10 ml doses. The clots were gently teased through a #60 
stainless steel mesh into saline, centrifuged, and the 
peripheral white blood cells (buffy coat) were removed.
Cells were counted in a hemocytometer and adjusted to a 
concentration of 1 x 10' cells per ml. Experimental ani­
mals received i.v. 2 ml of this suspension. To collect 
the peritoneal cells, sterile MEM was injected into the 
peritoneal cavity and then withdrawn together with the oil 
and placed in a cold separatory funnel. The aqueous layer 
containing the cells was withdrawn and the cells were washed 
twice in MEM, counted in a hemocytometer and adjusted to a
7final concentration of 1 x 10 cells per ml. Two ml of this 
suspension were given i.v. into each experimental animal.
The spleens from immune rabbits were teased through a stain­
less steel screen, washed 7 times in MEM, the cells were 
counted in a hemocytometer and adjusted to a concentration
7of 1 X 10' cells per ml. Two ml of the spleen suspension 
were given i.v. to each experimental animal.
Measurement of Tumors and Delayed Reactions 
Two diameters of the lesions were measured at right 
angles to one another and the approximate area was calcu­
lated by multiplying the two values. Thickness of the 
lesion was measured using a ”Schnelltester” system kroplin.
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Volximes of tumors were calculated by multiplying area by 
thickness. Delayed skin reactions were measured in the 
same manner and the volumes were calculated by using the 
formula suggested by Waksman, 195Ô:
V = (W X L X iT)0.75 
measured at right ^angles to one W = width of lesion in mm
another i, - length of lesion in ram
T = thickness of lesion in mm
Anti-Lymphocyte Serum (ALS)
Horse anti—(rabbit lymphocyte) serum (Microbiological) 
Associates Lot NO. 10972) was used as an immunological 
depressant in newborn animals. This serum was used either 
unabsorbed or absorbed with normal rabbit red blood cells.
Virus Neutralization Test 
Two-fold dilutions of the immune serum to be tested 
were made in sterile phosphate-buffered saline. To each of 
the dilutions of serum (.2 ml), .2 ml of virus suspension 
was added to give a final dilution of 10"^ of virus. The 
mixtures were incubated for 30 minutes at 37^C, and then 
injected (.2 ml) into the skin of normal rabbits. The 
development of lesions was observed for 10 days. The 
neutralization titer of the serum was taken as the highest 
dilution inhibiting tumor development.
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Isolation of Immunoglobulin 
The method used was that of Stelos as detailed in 
Weir’s Handbook of Experimental Immunology (1967). A 
12 5 ml volume of saturated ammonium sulphate solution (SAS), 
adjusted to pH 6.5 with concentration ammonium hydroxide, 
was added to 350 ml of serum (this gives a 26.35^ saturation 
of SAS). The mixture was allowed to stand 15 minutes and 
then centrifuged. The sediment was washed twice with 100 
ml of 40^ SAS, and re suspended in *9fo NaCl, re precipitated 
twice with 50$& SAS, and washed as above. The final sedi­
ment was then resuspended in .9^ NaCl, dialysed against 
.9^ NaCl, and finally dialysed against distilled water.
The precipitated protein was centrifuged and resuspended in 
phosphate-buffered saline pH 7.2 (PBS). This globulin 
solution was divided into two equal portions and one por­
tion was treated with 0.6^ 2-mercoptoethanol (2-ME), Sigma, 
St..Louis, Missouri. The 2-ME-treated portion was dialysed 
against PBS. A 5 nil alliquoit was lyophilized and weighed 
to determine the amount of globulin. Animals received 
9.4 mg of globulin in 5 ml.
Preparation of Soluble Mediators Derived from Rabbit Lympho­
cytes Presensitized with Complete Freund’s Ad.juvant (CFA)
The basic procedure was that of Mooney and Waksman 
(1970). The popliteal and axial lymph nodes were harvested 
from animals previously sensitized with CFA. The lymph
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nodes teased through sterile stainless steel mesh into 
#199 media (Grand Island Biological Supply Co., Oakland, 
California) with 100 units of penicillin, 100 ug strep­
tomycin per ml. The cells were washed once in 100/Earle*s 
(Grand Island Biological Supply Co., Oakland, California) 
and centrifuged at 250 x g for 10 minutes. Cells were 
resuspended in #199 and counted in a hemocytometer. This 
cell suspension was then passed through a separatory fun­
nel packed with 60 mesh glass beads. The glass bead column 
had previously been incubated at 37^C for ^ hour, covered 
with #199 media containing 20^ normal rabbit serum which 
had been heated at 56^0 for 30 minutes and centrifuged at 
27,000 X g. After placing the cells on the column, it was 
incubated at 37°C for 30 minutes. The cells and media were 
then drawn off the column and the column was washed with 
#199 media with 20^ normal rabbit serum until the elute was 
no longer cloudy. The suspension was centrifuged at 250 x g
for 10 minutes to collect the cells. The cells were counted
7and adjusted to a concentration of 1 x 10 cell per ml in 
#199 media containing 5^ normal rabbit serum, 100 units of 
penicillin and 100 ug streptomycin per ml. The lymphocyte 
suspension prepared in this manner was 90$̂  pure. Six ml 
quantities of the final cell suspension were placed in 30 
ml Falcon Plastic tissue culture bottles (Falcon Plastics, 
Los Angeles, California). They were incubated for 24 hours 
at 37^C. One-half of the bottles contained purified
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protein derivative (PPD) at a concentration of 25 ug per ml 
and the other half without PPD# After the incubation 
period the supernatants were pooled and centrifuged at 
400 X g for 10 minutes# The resulting supernatants were 
stored at -70^0 until needed#
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Chapter III
RESULTS
Immunity in Adult Rabbits
Passive Transfer of Immunity
The initial studies were performed to determine if 
resistance to SRF could be transferred from animals 
recovered from fibromatosis to normal animals. Allison 
(1966) and Allison and Friedman (1966) reported that a 
cell—mediated immune response is responsible for recovery 
and immunity to SRF infections. Spleen cells, PEC, whole 
blood, and serum from immune rabbits were injected i.v. in­
to groups of 4 animals each, 72 hours after i.d. inoculation
of 0.2 ml of MEM containing a 10"’̂  dilution of virus.
7Animals in group 1 received 2 x 10' PEC, those in group 2
7were given 2 x 10 spleen cells, those in group 3 were 
injected with 10 ml of whole blood, and those in group 4 
received 10 ml of serum. Animals in group 5 were not 
treated. The surface area of the tumor was determined daily, 
The results of this experiment are shown in Figure 1.
Spleen cells and PEC were eliminated from the protocol 
of later experiments, as they seemed to offer no protection. 
It was also decided to separate whole blood into serum and 
peripheral white blood cells. Four groups of four animals 
were used; animals in group 1 received 10 ml of immune
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Figure 1. The surface area of fibromas produced in rabbits infected by intra- dermal injection of a 10”^ dilution of fibroma peritoneal exudate cells, spleen cells, whole blood or serum from rabbits recovered from fibromatosis
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Figure 2 — The average surface area of
fibromas produced in rabbits by intra— dermal injection of a 10~^ dilution of fibroma virus 72 hours prior to treat­ment with serum, buffy coat cells and buffycoat cells + serum from animalsrecovered from fibromatosis
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7serum; those in group 2 were given 2 x 10' buffy coat cells, 
and those in group 3 were injected with 10 ml of immune 
serum plus 2 x 10^ buffy coat cells (i.v*) 72 hours after 
infection. A control group (4) received no treatment. The 
areas of the tumors were calculated daily (Figure 2). The 
results from these two studies indicate that resistance to 
the SRFV cannot be transferred with immune spleen cells or 
PEC. Some resistance can be transferred using immune serum 
and immune serum plus buffy coat cells. The second experi­
ment was repeated using groups of seven animals each. The 
volumes of the lesions rather than their areas were determined 
in this experiment (Figure 3). No significant resistance 
was transferred in this experiment.
Soluble Mediators
In some instances soluble products of.specifically- 
stimulated lymphocytes (soluble mediators) have been shown 
to suppress the growth of tumors (Bernstein, ^  al., 1971)• 
Soluble mediators were prepared and harvested as previously 
described. The supernatants were tested to determine whe­
ther they possessed the ability to induce a reaction simi­
lar to delayed cutaneous hypersensitivity. A .2 ml volume 
of supernatant fluid from PEC of rabbits sensitized with 
CFA which had been incubated in the presence of PPD was 
injected i.d. into two separate sites on the flanks of 
each of 2 normal rabbits. The same amount of supernatant
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fluid from the same sensitized cells incubated without PDD 
was injected into 2 other sites on these animals. Measure­
ments of the reactions were taken at 6, 12, 24 and 4Ô hours 
(Table 1). The soluble mediators possessing the ability to 
induce a skin reaction were tested for their ability to 
suppress the growth of fibromas. Stock fibroma virus was
—Zldiluted 10 in the soluble mediator. Two—tenths ml of this 
mixture was injected i.d. into 5 sites on each side of 4 
rabbits. Two control rabbits were inoculated with an equal 
amount of virus without soluble mediator. Skin reactions 
due to SRF were of the same magnitude as those previously 
noted. The tumors in the experimental animals enlarged 
and regressed at the same rate as those on the control 
animals. Thus, despite a strong skin reaction induced with 
soluble mediator, no protection was provided against tumor 
induction by the virus.
Resistance to Reinfection
Allison (1966) inoculated rabbits with fibroma virus 
at two i.d. sites and, at daily intervals thereafter, the 
animals were injected on a different site with infectious 
virus. Tumors developed at the original site as well as 
at sites inoculated with virus on days 2 to 4. At the site 
infected with virus on day 5 a delayed-type response 
occurred, but no tumor developed. A similar procedure was 
employed in this investigation to test susceptibility to 
reinfection with the virus. Five rabbits were injected
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i.d. with 0.2 ml of MEM containing a 10”  ̂dilution of the
stock virus suspension, and all animals developed tumors
which were first palpable on day 4* On this day and for
5 succeeding days, the animals received a single i.d.
injection of the same amount of virus. No tumors developed
on any of the animals, with the exception of the tumor
at the original inoculation site. Contrary to Allison's
results, injection of live virus failed to provoke delayed
—1 —2responses. Heat-killed suspensions of 10 and 10 
dilutions of the original suspension injected i.d. on day 
10 also failed to produce delayed reactions.
BCG Therapy in Normal Animals
Live BCG has been used in several instances to retard 
the growth of tumors and leukemias (Zbar, et ^ . ,  1971» 
Schwartz, et ^ . , 1971; Mat he, ^  , 1969; Larson, et al. *
1971). In a study devised to determine the effect of 
injection of viable BCG into established fibromas, 7 normal 
animals were injected i.d. at 6 sites on each flank with 
10"^ dilution of the original virus solution. As soon as 
the tumors were palpable (4 days) .2 ml of a BCG suspension 
containing approximately 4 x. 10^ organisms was injected into 
the base of the tumors present at alternate sites. During 
the first few days the tumors at the sites treated with BCG 
continued to grow at the same rate as those at the untreated 
sites. Later measurement of the size of the tumors on the
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tsOi Table 1. Volume of skin reactions induced in normal rabbits by intradermal injection of 0.2 ml of fluid harvested after incubation of peritoneal 
exudate cells of rabbits sensitized with CFA with or without PPD.
Time of Reading a b Ave. Vol. of 4 Sites Injected with 
Super, from Cells Incubated with PPD
Ave. Vol. of 4 Sites Injected 
with Super, from Cells 
Incubated w/o PPD
6 hours 28.6 mm̂ 0
12 hours 34*2 mm̂ 0
24 hours 35*2 mrâ 0
48 hours 9,2 mm^ 0
Volumes calculated by formula suggested by Waksman, 195^.
Formula (W x L x JT)0.75 = V
,3V = volume of lesion in mm'
W = width of lesion in mm 
L = le^th of lesion in mm 
T = thickness of lesion in mm
= Two sites on each of two rabbits
measured at right angles to one another
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treated animals became difficult since the reaction to BCG 
produced an added volume to the tumors. More métastasés 
were observed in the treated animals than in the controls,
BCG Therapy in BCG-Immune Animals
A similar study was performed using BCG-immunized 
animals. Five rabbits were given ,2 ml of BCG suspension
7i.v. containing 2.4 x. 10 viable units per ml. Three weeks 
later the animals were skin-tested by i.d. injection of .8 
ug of PPD in .2 ml volume, and all gave strongly positive 
skin-test reactions. Three non-immunized animals were 
employed as controls. All of the animals were injected i.d. 
at 6 sites on each flank with a 10"”̂  dilution of the stock 
virus suspension. When the tumors were palpable (4 days) 
they were injected into the base with either 4 x 10 viable 
BCG organisms, 8 ug of PPD, or normal sterile saline in 
volumes of .2 ml. Alternate tumors were treated with one of 
the preparations. Delayed skin reactions occurred at the 
site of injection of BCG and PPD in the immunized animals 
and reactions to BCG occurred in the non-immuni zed animals. 
All tumors, however, enlarged at approximately the same rate 
regardless of treatment.
Non-Specific Immunity with BCG
Another study was performed to determine whether BCG- 
immunized animals possessed non-specific immunity toward 
fibroma infection. Ten animals were injected i.v. with
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7.2 ml of a BCG suspension containing 2.4 x 10 viable units 
per ml. Three weeks later the animals were skin-tested 
with 8 ug PPD in .2 ml saline and all gave strong skin 
reactions. The BCG—immunized animals and 5 normal animals 
were injected i.d. with .2 ml of a 10“^ and 10“^ dilution 
of heat-inactivated original stock virus suspension in .2 
ml. Five BCG—immune rabbits served as control. The skin- 
test volumes are presented in Table 2.
Immunity in Newborn Animals
Resistance Induced by Passive Transfer of Immune Serum 
Tumors induced by fibroma virus in newborn rabbits 
have been reported to grow progressively until the host dies 
(Duran-Reynals, 1945» Allison, 1966). The initial investi­
gation of this problem was an attempt to transfer immunity 
from adult animals which had recovered from a fibroma infec­
tion to infected newborn animals. Adult animals were bled
by cardiac puncture 3 weeks after infection with fibroma
—1 —2virus, and were skin—tested with 10 and 10 dilutions of 
the original suspension of heat-inactivated virus. All skin 
tests were negative. The sera were pooled and used in all 
investigations with immune adult serum. Experimental ani­
mals were given a single i.d. injection of a 10~^ dilution 
of the original virus suspension 36 hours after birth. The 
litters of each were then divided into two groups of 
approximately equal numbers. One group of animals was
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injected i.p. with 5 ml of immune serum 24 and 43 hours 
after infection with virus, and the rabbits in the other 
group were not treated. The animals were observed for the 
appearance of tumors (Table 3)» At various intervals after 
the first virus injection, the animals were challenged by 
i.d. injection of the same amount of virus (Table 4) to 
demonstrate the presence or absence of active resistance 
to reinfection with SRF. A total of 10 ml of serum was 
found to protect almost all animals from virus infection.
All of the treated animals developed fibromas with a second 
virus challenge, while untreated animals did not.
Titration of Immune Serum
An attempt was made to determine the amount of immune 
adult serum needed to protect newborn rabbits which had 
been previously infected with fibroma virus. All dilutions 
of seinim were given i.p., and equal volumes were given 24 
and 43 hours after injection of virus. Rabbits were given 
an i.d. injection of .2 ml of a 10"^ dilution of stock virus 
suspension 36 hours after birth. Five ml of serum was 
sufficient to protect animals from developing tumors. These 
animals were observed for the appearance of tumors, and were 
re challenged with a single i.d. injection of .2 ml of 10“^ 
dilution of the original virus suspension at Ô weeks of age 
(Table 5).
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400 . Figure 4 - Average tumor volume of fibromas of normal rabbits compared to that of rabbits immunized three weeksprior to virus challenge with .2 ml of a BCG suspension containing 2.4 x 10? organisms per ml.
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N Table 2. Volumes of skin reactions of BCG- and fibroma-immune, fibroma-immune, and BCG-immune animals challenged with 10“  ̂and 10“  ̂dilutions of 
heat-inactivated fibroma virus and 6 ug of PPD.
Animal Volume of B ug PPD Skin-Test Lesion
Volume of 10“1 uiXucion of Heat-Inactivated 
Skin-Test Lesion
volume 01 iu-2 Dilu­
tion of Heat-Inacti­
vated Skin-Test Lesion
BCG- and 
Fibroma-Immune 1 147.0 16.2 9.82 30.0 25.6 3.6
3 75.6 19.2 0.0
4 49.5 7.2 1.2
5 159.6 8.4 0.06 133.9 75.6 6.07 37.1 5.0 5.08 99.0 7.2 4.0
9 19.8 32,0 3.010 24.3 6.4 3.6Average 77.6 20.3 3.6
Fibroma-Immune 1 0.0 32.0 0.02 0.0 7.2 0.0
3 0.0 0.0 0.0
4 0.0 0.0 0.0
5 0.0 0.0 0.0Average 0.0 7.8 0.0
BCG-Immune 1 80.0 0,0 0.0
2 130.0 0.0 0.0
3 49.6 0.0 0.0
4 94.3 0.0 0.0
5 92.4 0.0 0.0
_ _________
Average 89.1 0.0 0.0
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Volumes calculated in Table 1.
(A Table 3. Number of newborn rabbits (36 hours old) developing fibromas following i.d. challenge with a 10"̂  ̂dilution of 
stock SRFV. Controls not treated with specific immune serum. 
Treated animals injected i.p. with specific immune serum^.
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Litter No.
Treated Group Control Group
No./Group No./Tumors No./Group No./Tumors
1 3 0 1 1
2 5 0 3 3
3 5 0 3 3
4 5 1 5 5
5 5 0 6 6
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= A total of 10 ml of serum was administered to each treated 
animal, 5 ml at 24 hours and 5 ml at 48 hours after virus 
challenge.
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-4- Table 4. Number of newborn rabbits developing fibromas on second i.d. challenge with a 10~4 
dilution of SRFV. Controls not treated with specific 
immune serum. Treated animals injected i.p, with 
specific immune serum at 50 and 75 hours of age.
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Age at Second Treated Group Control GroupVirus Challenge No./Group No,/Tumors No./Group No./Tumors
1 4 weeks 3 2 1 0
2 8 weeks 5 5 3 0
3 6 weeks 5 5 3 0
4 5 weeks 5 4 5 0
5 7 weeks 5 5 6 0
All control animals developed tumors following primary challenge with same 
dilution of virus.
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inen Table 5. Effect of varying the amount of specific immune serum given by i.p. injection to newborn animals on the number of animals 
which develop fibromas.
COCO
CDQ.
Total Serum Adminis. No. In Group No. of Tumors No. of Tumors When 
Challenged at 8 Wks.
5 ml. 4 1 3
2.5 ml. 4 4 0
1.25 ml. 4 4 0
0 0 4 0
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Serum administered in 2 i.p. injections, the total amount of serum given at
24 hours and the second half at 48 hours after virus challenge.
Animals were infected with a .2 ml injection of a 10' 
virus suspension at 36 hours of age. dilution of the stock
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Serum Fractionation
Fourteen 36-hour old rabbits were given i.d. .2 ml 
of a 10"^ dilution of the stock virus suspension. Five of 
these rabbits received 9.4 mg of the 2-ME treated globulin 
preparation, five were given 9.4 mg of the untreated pre­
paration, and four were not treated. The animals were 
observed for tumor development. None of the treated ani­
mals developed tumors.
Resistance Induced by Transfer of Normal Adult Macrophages 
A group of seven rabbits, 36-hours old, was selected. 
Each animal was injected i.d. with .2 ml of a 10~^ dilution 
of the original virus suspension. Twenty-four hours later
n4 animals were given i.p. 6.1 x 10 normal adult macrophages 
in 1 ml. All of these animals and the 3 control animals 
developed tumors in 5 days. The tumors on animals treated 
with macrophage were larger and metastasis were more preva­
lent. All of the tumors in both groups regressed at the 
same rate and eventually disappeared. None of the animals 
developed tumors when injected i.d. with 0.2 ml of a 10 ^ 
dilution of the original virus suspension administered when 
the animals were 5 weeks of age.
Heat-Inactivated Serum
Immune adult rabbit serum was heated at 56^0 for 2 
hours. Two 5 ml i.p. injections were given to 4 animals 
which had received an injection of a 10”^ dilution of the
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original virus suspension. One sérum injection was given 
24 hours and the other 48 hours after virus injection. Only 
one of the four treated animals developed a tumor in 5 days, 
while all five of the control animals developed tumors in 
5 days.
Death Rate in Newborn Rabbits Infected with SRF
Contrary to results obtained by Duran-Reynals (1945) 
and Allison (1966) no fatalities attributed to the SRFV 
occurred among the young rabbits used in these studies.
Some tumors in newborn animals eventually attained a size 
approximating 1/3 to 1/2 that of the animal, but all of these 
eventually regressed. None of the animals recovered from 
fibromatosis could be reinfected at a later date.
Virus Neutralization Test
A group of nine rabbits was given a single i.d. dose of 
virus 36 hours after birth, and three of these were treated 
with 10 ml of specific immune serum. No tumors developed in 
these animals. The remaining six animals, which were not 
treated, developed tumors. Eight weeks later serum was 
obtained from all nine rabbits and a virus neutralization 
test was performed. There were no neutralizing antibodies 
in the serum of treated animals ; however, the serums of the 
infected control rabbits contained antibodies with titers 
ranging from 1:2 to 1:8 (Table 6). When challenged with a 
single .2 ml injection of a lO”^ dilution of virus, 24 hours
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Table 6. Correlation of virus neutralizing titers against SRFV to 
the number of fibromas developed on challenge with an i.p. injection 
of a 10~^ dilution of the original virus suspension.
Virus-Neutralizing Tumor DevelopmentGroup Animal Titer Challenged at 3b hr. Challenged at 8 wks.
1 — +
Treated 2 - +
3 - +
1 1:2 +
2 1:4 + -
Untreated 3 1:4 + -
k 1:2 + -
5 1:8 + —
6 1:4 +
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Ail animais injected with .2 ml of 10 dilution of SRFV i.d. at 36 hours of age. 
Treated animals given specific immune serum and did not develop tumors on initial 
challenge. Untreated animals all developed tumors on initial virus challenge. 
Normal rabbit serum possessed no virus-neutralizing titer. Virus incubated with 
saline was fully active in tumor induction.
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after the serum sample was observed, treated animals deve­
loped tumors but untreated rabbits did not* A control of 
normal rabbit serum had no virus—neutralizing capacity, and 
a second control of virus incubated in saline was fully 
active in tumor induction. The immune serum pool had a 
titer of 1:4.
Treatment with ALS
Seven 36-hour old rabbits were injected i.d. with .2 
—Aml of a 10 ^ dilution of the original virus suspension.
Four animals were treated with three 1 ml injections of ALS 
i.p. at 4Ô hour intervals. Three untreated animals served 
as controls. The animals were observed for tumor develop­
ment and growth. The ALS-treated animals developed tumors 
sooner and the tumors on these animals grew larger than 
those on untreated animals.
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Chapter IV
DISCUSSION
Immunity in Adult Rabbits
Passive Transfer of Immunity
Data presented in Figures 1 and 2 indicate that intra­
venous injection of serum, whole blood, and peripheral white 
blood cells plus serum from animals recovered from fibroma 
infections influences the course of infections with fibroma 
virus in adult rabbits. In these experiments, injection of 
the above substances was withheld until 72 hours after the 
animals were infected in order to allow the virus to become 
firmly established prior to institution of therapy. Immune 
serum does contain virus-neutralizing antibodies but these 
may be ineffective from a therapeutic standpoint. The 
criterion for protection was reduction of the average area 
of tumors in the treated animals as compared to that in 
control rabbits. Spleen cells, peritoneal exudate cells and 
peripheral white blood cells which were washed to decrease 
the effect of serum, did not influence the effects of 
infection.
Evidence obtained by Allison (1966) and Allison and 
Friedman (1966) indicated that recovery from and immunity to 
SRF is dependent upon cell-mediated immune responses. If 
only cell—mediated responses are responsible for immunity as
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Allison and Friedman postulate, passive transfer of 
resistance should be accomplished by transfer of sensi­
tized lymphocytes or macrophages, but not by transfer of 
serum. Our findings show that passive transfer of cells 
from immune animals to animals infected 72 hours previously 
does not confer resistance to infection; however, humoral 
antibodies do confer some degree of immunity. It appears 
(Figures 1 and 2) that specific immune serum plus peri­
pheral white blood cells gives the greatest amount of pro­
tection to infected recipient animals. A plausible expla­
nation for this observation is a synergistic action of 
antibodies and cells. The serum could contain opsonizing 
antibodies which prepare virus particles or induced tumor 
cells for phagocytosis and subsequent destruction by macro­
phages in the buffy coat cells. It is possible that greater 
protection might be afforded if immune serum or immune serum 
and buffy coat cells were administered soon after infection 
with virus rather than after 72 hours. Evidence for this 
will be discussed later. The results in Figure 3, using 
decreased tumor volume as a criterion, indicate that no 
significant protection of adult animals was obtained when 
they were treated with specific immune serum, immune buffy 
coat cells, or cells with immune serum 72 hours after virus 
infection. Further study in this area is indicated, 
expecially an investigation of the relationship of time of 
treatment to the amount of protection given by specific
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immune serum.
The above results show that neither spleen cells,
PEC, nor circulating cells from rabbits recovered from 
fibromatosis are capable of conferring resistance to SRFV 
in adult rabbits infected 72 hours previously with this 
agent. The influence of immune serum also seems debatable. 
However, since it is stated that cell—mediated responses 
are important in the recovery of animals from virus infec­
tions, other studies were done to determine if non-specific 
resistance could be established and if ^  vitro correlates 
of cell-mediated immunity could be demonstrated.
Soluble Mediators
Skin reactive factor (SM-SRF) is one of the soluble 
mediators produced when sensitized lymphocytes are exposed 
to specific antigen in vitro (Mooney and Waksman, 1970). 
Following injection into normal animals, SRF produces a 
lesion which may be considered as a compressed delayed 
reaction. Specific antigen given i.d. into sensitized 
guinea pigs produces a reaction which appears in 6 to 10 
hours, reaches a peak in 24 to 46 hours, and gradually 
decreases in size. The same antigen injected i.d. into a 
normal guinea pig will not produce a reaction unless the 
agent is a toxic one. On the other hand, SM-SRF injected 
into a normal animal produces a reaction which develops in 
2 to 4 hours, reaches a peak in 6 to 12 hours, and then
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gradually disappears. The skin reaction is fore-shortened 
because the production of the active material has been 
accomplished vitro rather than ija vivo, Heise, ^  al.
(i960) have shown that production of SRF is not demonstrable 
in tissue culture until 9 hours after sensitized lymphocytes 
and specific antigen are mixed and incubated at 37°C,
SM-SRF produced in this laboratory by incubation of PEC from 
rabbits sensitized to CFA together with PPD causes a skin 
reaction when injected i.d, into normal rabbits. The lesion, 
however, is well-developed in 6 hours, reaches a peak in 12 
to 24 hours, and disappears by 46 hours. Active delayed 
reactions in sensitized rabbits induced by injection of 
specific antigen reach their maximum size in 24 to 40 hours 
and persist for several days. In experiments performed by 
Bernstein, ^  , (1971) the soluble products of speci­
fically-stimulated lymphocytes (soluble mediators) were 
mixed with ascites cells from the sixth generation of a 
transplantable hepatoma and injected i.d, into the skin of 
normal guinea pigs. Tumor growth was suppressed in guinea 
pigs inoculated with this mixture. The soluble mediator 
preparation used by Bernstein, et possessed the ability
to produce a reaction similar in appearance to delayed 
cutaneous hypersensitivity, as did the preparation used in 
this study. The SM—SRF reaction, when examined histolo­
gically, shows an accumulation of mononuclear cells (Bernstein, 
et al, 1971)* When rabbits were injected with SRF suspended
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in soluble mediator prepared from lymphocytes of rabbits 
specifically-stimulated with CFA, no inhibition of tumor 
growth was observed* It must be assumed that mononuclear 
cells which accumulate at the reaction sites are incapable 
of phagocytosing and destroying the virus particles. This 
is again evidence against the participation of cell-mediated 
immunity in immunity against SRF,
Resistance to Reinfection
In the original study by Allison (1966) it was found 
that adult rabbits are immune to reinfection with SRFV 
days after primary infection. Our experiments confirm the 
observation that immunity to reinfection is developed by 5 
days after infection. Contrary to Allison’s results, how­
ever, no cutaneous delayed hypersensitivity response could 
be elicited in infected animals by i.d. injection of either 
live or heat-inactivated virus.
BCG Therapy in Normal Animals
In some instances, (Zbar, ^  al•» 1971) viable BCG 
injected directly into tumors of normal animals will cause 
the tumor to regress. In the SRF system, however, increased 
rate of tumor regression in treated animals was not observed. 
Viable BCG injected into the base of the tumor causes an 
active infection at that site. It appears that the lymphoid 
cells which aggregate at the site of injection of BCG are 
ineffective against SRF even though a typical tubercle (a
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manifestation of delayed hypersensitivity) is formed at 
the site.
BCG Therapy in BCG-Immune Animals
Although strongly positive skin reactions develop when 
viable BCG or Ô ug of PPD is injected into the base of 
fibromas present on rabbits previously immunized with BCG, 
no evidence of protection is observed. From this data, it 
would appear that the macrophages which assemble in the 
delayed reaction are incapable of phagocytosing and destroy­
ing either the virus particles or the fibroma cells.
Non-Specific Immunity with BCG
The results presented in Figure 4 indicate that BCG- 
immune animals do not possess non-specific immunity toward 
SRF. Tumors induced in BCG—immune animals appear, enlarge, 
and regress at the same rate as those in normal animals. 
Thus, while BCG-induced non-specific immunity does enhance 
immunity to certain tumors and leukemias in man and animals
(Zbar, et al., 1971» Schwartz, et al., 1971» Mat he, et al.,
1971; Larson, £t al., 1971), it does not appear to be 
effective in the SRF system. An interesting observation 
was made when animals in this experiment were skin-tested 
with PPD and a suspension of heat-inactivated virus. The 
results in Table 2 indicate that BCG has an adjuvant effect 
with respect to the induction of specific delayed
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hypersensitivity in rabbits subsequently infected with SRF. 
Although BCG immunization gave no protection, it did 
increase the volume of skin-test lesions in animals immune 
to both BCG and SRF. These findings indicate that a delayed 
skin response to SRF cannot be correlated with immunity to 
the virus. Delayed hypersensitivity reactions in animals 
immunized with BCG are much larger than those in animals 
immunized with SRF, while tumor size, growth, and regression 
are essentially identical in the two groups. The positive 
skin—test reactions against SRF observed in animals immu­
nized with BCG and SRF were the only ones obtained in these 
studies, although SRF-iramune animals were skin-tested in an 
identical manner. It is apparent from discussion presented 
thus far that no supporting evidence for the participation 
of delayed hypersensitivity in immunity to SRF was obtained 
in this study.
Immunity in Newborn Rabbits
Resistance Induced by Passive Transfer of Immune Serum 
New born rabbits have been shown to be extremely 
sensitive to tumor induction by SRFV ( Duran-Reynals, 1940, 
1945; Allison, 1966; Allison and Friedman, 1966). For this 
reason passive transfer of resistance by either cells or 
serum would require that the factor be quite effective. 
Since the results previously discussed show that lymphoid 
cells of animals recovered from fibromatosis are not
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effective In transferring resistance to normal rabbits, 
the following studies were undertaken to determine if trans­
fer of immune serum could confer resistance to newborn ani­
mals. The results indicate that i.p. injection of 10 ml 
of specific immune serum into newborn rabbits infected with 
fibroma virus 24 hours prior to treatment results in almost 
complete suppression of tumor growth (Table 3)* All of the 
untreated rabbits develop tumors one week after virus 
challenge. Thus, administration of immune serum to newborn 
rabbits protects them against infection with SRFV. This 
protection cannot be attributed to neutralization of the 
initial inoculum of virus by serum, since the animals were 
infected 24 hours before treatment. It is interesting to 
observe that following challenge with a second injection of 
virus, all of the animals which developed tumors on initial 
challenge were resistant to reinfection. All animals treated 
with serum which did not develop tumors on primary challenge 
did so following the second challenge with virus. The lone 
animal treated with serum which developed a fibroma follow­
ing primary challenge with virus was immune to the secondary 
challenge. These findings indicate that treatment with spe­
cific immune serum resulting in prevention of tumor—formation 
interferes with the animal’s ability to develop active 
immunity to the virus or the tumor cells. The only reason 
which seems to explain this situation is that immune serum 
prevents the spread of virus from cell to cell and, as a
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consequence, the amount of viral antigen released is 
insufficient to stimulate the immune system to produce the 
factors necessary for active immunity. This situation is 
remindful of that occurring during the treatment of measles 
with immune serum. Treatment of exposed children too soon 
after their exposure to a case of measles will prevent 
infection, but will not result in the production of active 
immunity. It is evident that passive immunity may be 
achieved by transfer of specific immune serum to newborn 
rabbits. The minimal amount of specific immune serum effec­
tive in preventing tumor formation by newborn rabbits is 
5 ml of the serum pool used in these studies. This repre­
sents a large fraction of the total serum pool of these 
animals. Studies performed using r globulin preparations 
indicate that the protecting antibodies are in the ^ O 
immunoglobulin.
Heat-Inactivated Serum
Ten ml of serum heated at $6^0 for 2 hours given in 
two i.p. injections to a newborn rabbit infected 24 hours 
previously with SRFV was still active in the preparation of 
tumor development. Based upon this evidence, it can be 
assumed that the active portion of the serum is non-heat 
labile.
Two in vitro studies support the idea that humoral 
antibodies are involved in regression of SRF-induced tumors.
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Tompkins, et aT., (1970) have shown that sera from rabbits 
with regressed fibromas will react in a specific manner 
with the surface of viable fibroma—infected cells. This 
evidence implies that animals infected with fibroma virus 
produce antibody with the capacity to bind with the surface 
of infected cells, but gives no indication as to the 
sequelae of this primary interaction. Singh, et al.,
(1972) presented evidence that animals bearing SRF-induced 
tumors produce antibodies cytotoxic to tissue culture cells 
infected with the virus. This study also showed that 19S 
antibodies appeared on the 7th day of infection and reached 
peak titer on day 13» and disappeared by day 17. On the 
other hand, 7S antibody was barely detectable on day 7» 
reached maximum titer on day 13 » and remained high for at 
least $0 days.
Resistance Induced by Transfer of Normal Adult Macrophages 
The findings of Zisman, ^  aA. (1970) and of Duran- 
Reynals (1940, 1945), Allison (1966), and Allison and 
Friedman (1966) demonstrated that young animals are more 
susceptible to infection with certain viruses than are older 
animals. It was shown by Zisman, et (1970) that admin­
istration of macrophages from older mice increased the 
resistance of suckling mice to infection with herpes virus. 
The other workers (Duran-Reynals 1940, 1943; Allison 1966; 
Allison and Friedman 1966) showed that young rabbits infected
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
50
with SRFV developed larger tumors than did adult animals*
Our studies however, fail to show that administration of 
macrophages of normal adult rabbits to newborn rabbits 
induces resistance to infection with SRFV* Rather, it 
appears that newborn rabbits treated with macrophages of 
normal adult rabbits develop a greater number of metas­
tatic lesions than do normal suckling rabbits. The 
metastatic lesions in the treated animal may occur when 
macrophages engulf virus particles which they are unable 
to destroy. The virus is then disseminated by the macro­
phages and freed by their death. A metastatic lesion may 
then develop if the virus is not pahgocytosed and destroyed 
by another macrophage. This observation would seem to 
indicate that the animals possess no active immunity to the 
SRF at this age. If such immunity were present and anti­
bodies active against the virus were produced the observed 
métastasés would not occur. Further study is indicated in 
this area using specific immune macrophages and normal 
macrophages given with an amount of specific immune serum 
insufficient in itself to protect the animal from fibroma 
infection.
Virus Neutralization Test
Data in Table 5 indicates that the virus neutralization 
titer of a rabbit's serum can be correlated to the animal's 
resistance to reinfection with the SRF. Animals treated
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with specific immune serum which prevented tumor induction 
on primary challenge developed no virus neutralizing titer 
and were susceptible to tumor induction when rechallenged 
at a later date* This evidence supports the concept that 
true passive immunity is transferred with specific immune 
serum.
Treatment with ALS
Animals treated with ALS 24 hours after virus infection 
develop tumors sooner than non-treated control animals. The 
tumors in the treated animals also grow to a larger size 
than those in the controls. This is to be expected as ALS 
depresses the animal’s immune system, allowing the tumors 
to grow to a much larger size.
There are basically two types of specific immunity, 
humoral and cell-mediated. The former is characterized by 
specific antibodies and the latter by specifically- 
stimulated lymphocytes. Humoral immunity may be transferred 
from one animal to another with serum, cell-mediated immu­
nity may be transferred with lymphoid cells. Both types of 
immunity may be involved in recovery from viral infections. 
It appears that in measles infection antibody plays the more 
important role, while in herpes simplex infection it is cell- 
mediated immunity (Allison, 1966) which is more important. 
These are only two examples of many virus infections in
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which one type of immunity or the other appears to play 
the major role.
In our studies with adult rabbits infected with the 
SRFV, it was shown that resistance to the infection could 
not be transferred with lymphoid cells from immune animals* 
BCG, which enhances the cell-mediated response, was also 
ineffective in enhancing resistance to SRFV in both normal 
and BCG—immune animals. These results indicate that cell- 
mediated immunity plays little if any role in resistance 
to SRFV. Animals immunized with both BCG and SRFV did, 
however, display a positive delayed cutaneous hypersensi­
tivity reaction when injected i.d. with heat-inactivated 
virus. SRFV-immune animals did not give positive skin 
reactions when injected in the same manner. This indicates 
that a positive delayed cutaneous hypersensitivity reaction 
cannot be correlated to cell-mediated immunity against the 
SRF. Attempts to transfer resistance to the SRF with immune 
serum were not successful in all cases. A possibility exists 
that immune serum would be more effective if administered 
sooner after virus infection, i.e. 24 hours.
In newborn animals it was observed that immune serum 
given 24 hours after virus infection will passively transfer 
resistance in virtually all of the treated animals. These 
animals, however, did not develop active resistance to the 
virus and developed tumors when challenged a second time 
with the virus. All control animals which received no
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treatment developed tumors on primary virus challenge, but 
were immune to a second challenge of virus # The activity 
against SRFV appears to be the IgG portion of the serum.
In vitro support for this concept is found in work by 
Singh, (1972). ALS, which depresses the immune
response, lessens an animal’s ability to resist fibroma 
infection. Since ALS inhibits cell—mediated immunity more 
than humoral immunity, it appears that cell-mediated immun­
ity may also play a role in SRFV resistance. Normal adult 
macrophages do not inhibit SRFV infection when given to 
infected newborn rabbits. This again indicates that cell- 
mediated immunity is less important than humoral antibody 
in resistance to the SRFV infections.
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Chapter V 
SUMMARY
The Shope rabbit fibroma virus (SRFV) induces a local, 
benign tumor which spontaneously regresses in adult rabbits. 
The virus in some instances induces a fatal generalized 
disease in newborn rabbits. Previous work by Allison (1966) 
and Allison and Friedman (1966) attributes resistance to 
SRFV to a cell-mediated immune response.
Attempts were made passively to transfer immunity from 
SRFV-immune animals to adult domestic rabbits infected 72 
hours previously with the virus. Immune peritoneal exudate 
cells, immune spleen cells, and immune peripheral white 
blood cells were ineffective in transferring resistance. 
Immune serum, immune whole blood and immune serum mixed 
with immune peripheral white blood cells were effective to 
a small degree.
Attempts to produce non-specific immunity with BCG 
and soluble mediator-skin reaction factor were unsuccessful. 
Delayed hypersensitivity reactions to heat-inactivated virus 
suspensions appeared only in animals which were immune to 
both BCG and SRFV.
Passive transfer of resistance by immune serum was 
accomplished in newborn rabbits infected with virus at 36 
hours of age. Five ml of immune serum was sufficient to 
protect the animals. The active factor in the serum is
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non-heat labile and appears to be 7S or IgG immunoglobulin. 
Animals treated with immune serum after virus challenge at 
36 hours developed no tumors, however, when challenged 
again with virus these animals developed tumors. Animals 
not treated with serum all developed tumors on initial virus 
challenge, but were immune to a second virus challenge. 
Treated animals developed no virus neutralizing titers after 
initial virus challenge, while untreated animals did.
Newborn animals treated with normal adult macrophages 
after virus infection developed tumors with more tendency 
to metastasis than untreated controls.
Treatment with anti—lymphocyte serum caused tumors to 
appear earlier and grow larger in newborn animals.
From these results we postulate that resistance to 
SRFV is not completely dependent upon a cell-mediated immune 
response, but rather humoral antibodies.
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